Global Synthetic Cannabinoids Market
Pharmaceuticals

Synthetic Cannabinoids Industry Growth Expected to Reach $4.29 Billion by 2029 at a CAGR of 17.9% | Segmentation and Growth Opportunities

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Synthetic Cannabinoids Market Growth in 2025?

The market size of synthetic cannabinoids has experienced a significant expansion in the past few years. From being valued at $1.88 billion in 2024, it is projected to increase to $2.22 billion in 2025, representing a compound annual growth rate (CAGR) of 18.3%. The unprecedented growth observed in the historical period is due to factors such as rising demands for substitute drugs, an increased user base for cannabis, growing utilisation in pharmaceutical applications, increasing demand for legal highs, and a notable shift towards self-medication.

What Is the Forecast for the Synthetic Cannabinoids Market Size Through 2029?

In the forthcoming years, the synthetic cannabinoids market is poised for swift expansion, anticipated to reach $4.30 billion by 2029, witnessing a compound annual growth rate (CAGR) of 17.9%. Factors contributing to this rise during the prognosis period include the soaring demand for designer drugs, an increasing trend for legalization of cannabis, enhanced online availability of synthetic drugs, the expanding popularity of vaping, and an upswing in the customization of cannabinoid products. Notable trends for the forecast duration encompass progressed forensic toxicology tactics, employing machine learning for recognizing chemical patterns, tracking of illicit drugs via cloud-based systems, breakthroughs in synthetic cannabinoid concoctions, and the generation of innovative cannabinoid analogs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What are the Key Market Players in Synthetic Cannabinoids Market and How They’re Evolving?

Major companies operating in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd.

What Are the Primary Growth Drivers in the Synthetic Cannabinoids Market?

The synthetic cannabinoids market is predicted to grow, fueled by the increasing need for treatments for neurological disorders. Neurological disorders, which hinder movement, sensation, cognition, or general functioning, are conditions affecting the brain, spinal cord, and nerves. These disorders are becoming more prevalent, largely due to an aging world population and diseases like Alzheimer’s becoming more frequent with age because of brain aging and accumulated cell damage. Synthetic cannabinoids have the potential to offer relief from these disorders’ symptoms as they target cannabinoid receptors in the brain and play a role in regulating neurotransmitter activity. For example, the Belgium-based European Brain Council reported in September 2024 that 7 million people in Europe are currently living with Alzheimer’s disease. This number is predicted to double by 2030 to 14 million due to aging, creating a significant global public health issue. Therefore, the growing need for neurological disorder treatments fuels the expansion of the synthetic cannabinoids market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

What Are the Leading Segments in the Global Synthetic Cannabinoids Industry?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

What Are the Key Market Trends in the Synthetic Cannabinoids Industry?

The synthetic cannabinoids market is being shaped by major companies that are focusing on the development of advanced solutions such as fungal expression systems. By genetically engineering fungi to biologically produce synthetic cannabinoids, businesses can boost production efficacy and lower costs in a scalable and sustainable manner. An alternative to plant extraction or chemical synthesis, this method is suitable for high-purity production for research and pharmaceutical purposes. For instance, Dyadic International Inc., a US biotech firm, introduced C1-cell protein production platform in January 2022 for the production of synthetic cannabinoids. This unique approach employs filamentous fungal cell factories to produce cannabinoids like cannabidiol (CBD) and its precursors in a more cost-effective and sustainable way. Additionally, it is an environmentally friendly and energy-efficient process capable of creating purer cannabinoids in compliance with regulations, potentially useful in treating areas such as inflammation, chronic pain, and other health conditions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

What Is the Regional Outlook for the Synthetic Cannabinoids Market?

North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23536

This Report Delivers Insight On:

1. How big is the synthetic cannabinoids market, and how is it changing globally?

2. Who are the major companies in the synthetic cannabinoids market, and how are they performing?

3. What are the key opportunities and risks in the synthetic cannabinoids market right now?

4. Which products or customer segments are growing the most in the synthetic cannabinoids market?

5. What factors are helping or slowing down the growth of the synthetic cannabinoids market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model